Literature DB >> 16815217

Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease.

Thomas J Montine1, Randall L Woltjer, Catherine Pan, Kathleen S Montine, Jing Zhang.   

Abstract

Systems biology offers enormous potential to understand the complexity of human brain aging and neurodegenerative diseases. Proteomics has an important role in these investigations because of its unique strengths and because of the potential central pathogenic contribution of pathological protein to several of these diseases. Here we have reviewed the methods and presented some examples of liquid chromatography-electrospray ionization-tandem mass spectrometry-based proteomics, with and without quantification using isotope-coded affinity tags, in the investigation of aging and Alzheimer's disease. As protocols and methods for improved quantitative high-throughput proteomics constantly improve, this approach will likely continue to provide deeper insight into human brain aging and neurodegenerative diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16815217      PMCID: PMC3593378          DOI: 10.1016/j.nurx.2006.05.002

Source DB:  PubMed          Journal:  NeuroRx        ISSN: 1545-5343


  35 in total

1.  Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry.

Authors:  Xiao-Jun Li; Hui Zhang; Jeffrey A Ranish; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-12-01       Impact factor: 6.986

2.  Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection.

Authors:  Lujian Liao; Dongmei Cheng; Jian Wang; Duc M Duong; Tatyana G Losik; Marla Gearing; Howard D Rees; James J Lah; Allan I Levey; Junmin Peng
Journal:  J Biol Chem       Date:  2004-06-25       Impact factor: 5.157

Review 3.  Functional genomics and proteomics: application in neurosciences.

Authors:  K E Wilson; M M Ryan; J E Prime; D P Pashby; P R Orange; G O'Beirne; J G Whateley; S Bahn; C M Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

4.  Cerebrospinal fluid biomarkers in Alzheimer disease: a fractional improvement?

Authors:  Douglas Galasko
Journal:  Arch Neurol       Date:  2003-09

5.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags.

Authors:  S P Gygi; B Rist; S A Gerber; F Turecek; M H Gelb; R Aebersold
Journal:  Nat Biotechnol       Date:  1999-10       Impact factor: 54.908

Review 6.  New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase.

Authors:  M A Sirover
Journal:  Biochim Biophys Acta       Date:  1999-07-13

7.  Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family.

Authors:  Yonghong Li; Petra Nowotny; Peter Holmans; Scott Smemo; John S K Kauwe; Anthony L Hinrichs; Kristina Tacey; Lisa Doil; Ryan van Luchene; Veronica Garcia; Charles Rowland; Steve Schrodi; Diane Leong; Goran Gogic; Joanne Chan; Anibal Cravchik; David Ross; Kit Lau; Shirley Kwok; Sheng-Yung Chang; Joe Catanese; John Sninsky; Thomas J White; John Hardy; John Powell; Simon Lovestone; John C Morris; Leon Thal; Michael Owen; Julie Williams; Alison Goate; Andrew Grupe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-26       Impact factor: 11.205

8.  A new and sensitive on-line liquid chromatography/mass spectrometric approach for top-down protein analysis: the comprehensive analysis of human growth hormone in an E. coli lysate using a hybrid linear ion trap/Fourier transform ion cyclotron resonance mass spectrometer.

Authors:  Shiaw-Lin Wu; Ian Jardine; William S Hancock; Barry L Karger
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

9.  Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

Authors:  Christopher M Clark; Sharon Xie; Jesse Chittams; Douglas Ewbank; Elaine Peskind; Douglas Galasko; John C Morris; Daniel W McKeel; Martin Farlow; Sharon L Weitlauf; Joseph Quinn; Jeffrey Kaye; David Knopman; Hiroyuki Arai; Rachelle S Doody; Charles DeCarli; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2003-12

Review 10.  CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.

Authors:  Niels Andreasen; Magnus Sjögren; Kaj Blennow
Journal:  World J Biol Psychiatry       Date:  2003-10       Impact factor: 4.132

View more
  7 in total

Review 1.  Approaches for targeted proteomics and its potential applications in neuroscience.

Authors:  Sumit Sethi; Dipti Chourasia; Ishwar S Parhar
Journal:  J Biosci       Date:  2015-09       Impact factor: 1.826

2.  Separation of biological proteins by liquid chromatography.

Authors:  Imran Ali; Hassan Y Aboul-Enein; Prashant Singh; Rakesh Singh; Bhavtosh Sharma
Journal:  Saudi Pharm J       Date:  2010-02-13       Impact factor: 4.330

Review 3.  Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.

Authors:  Leila H Choe; Brenda G Werner; Kelvin H Lee
Journal:  NeuroRx       Date:  2006-07

4.  Factors associated with resistance to dementia despite high Alzheimer disease pathology.

Authors:  D Erten-Lyons; R L Woltjer; H Dodge; R Nixon; R Vorobik; J F Calvert; M Leahy; T Montine; J Kaye
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

5.  Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry.

Authors:  Qiangwei Xia; Dongmei Cheng; Duc M Duong; Marla Gearing; James J Lah; Allan I Levey; Junmin Peng
Journal:  J Proteome Res       Date:  2008-05-30       Impact factor: 4.466

6.  Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.

Authors:  Giuseppe Paglia; Matteo Stocchero; Stefano Cacciatore; Steven Lai; Peggi Angel; Mohammad Tauqeer Alam; Markus Keller; Markus Ralser; Giuseppe Astarita
Journal:  J Proteome Res       Date:  2016-01-12       Impact factor: 4.466

7.  Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.

Authors:  Johannes C M Schlachetzki; Bernd L Fiebich; Elisabeth Haake; Antonio C P de Oliveira; Eduardo Candelario-Jalil; Michael T Heneka; Michael Hüll
Journal:  J Neuroinflammation       Date:  2010-01-11       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.